Methods of treatment
US10004725B2 · kind B2 · utility
17Cited by
36References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2016 |
| Grant date | Jun 26, 2018 |
| Priority date | — |
| Expiry date | Apr 3, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates to use of certain aldehyde compounds for treating pulmonary fibrosis, hypoxia, and connective tissue and autoimmune disease such as scleroderma, lupus, arthritis and related conditions in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.